Outlook Therapeutics, Inc.
OTLK· Nasdaq
OTLKOutlook Therapeutics, Inc.
Filed Dec 29, 2022 · 10-K · 90 days after period end · 0001558370-22-019036
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | — | — | $5.85M |
| Net Income | -$14.35M | -$13.40M | -$9.92M | -$10.10M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Outlook Therapeutics, Inc. · CIK 1649989 · Engraved from SEC EDGAR
ended Sep 30, 2022 · filed Dec 29, 2022 · 90 d after period end
